Event Date
Bladder Cancer is a heterogeneous disease with the majority of patients presenting with non-muscle invasive and 25% with muscle invasive disease. There is a sea change over the past decade as the forces of a forward-thinking regulatory environment, discovery at the genomic level, and practice changing clinical trials have converged to improve the lives of our patients.
About the Series
The Distinguished Speakers in Oncology series brings nationally and internationally recognized leaders in cancer research to UC Davis to share transformative discoveries across the field. Hosted by the UC Davis Comprehensive Cancer Center, the series fosters dialogue and collaboration among scholars, staff, faculty, and community members around advances shaping the future of cancer research and care.